Debt-to-Equity Ratio
Updated 56h ago
Sector Performance
56th percentileMDLZ
0.82x
Sector Median
0.73x
Sector Avg
0.09x
Deep Analysis
The debt-to-equity ratio measures how much debt a company uses to finance its operations relative to shareholders' equity; a ratio of 0.82x means MDLZ has $0.82 of debt for every $1 of equity, indicating moderate leverage.
Compared to sector peers, MDLZ's ratio of 0.82x exceeds the sector median of 0.73x and places it at the 56th percentile, meaning it has more debt than 56% of peers but still within a typical range. No trend data is available — the year-over-year and quarter-over-quarter changes are both labeled N/A, and the company shows only a single historical value, so the direction of the metric cannot be assessed. Because the current level is only slightly above the sector median and no trend exists to indicate whether leverage is rising or falling, the risk profile appears average. This metric neither supports nor contradicts the overall NEUTRAL verdict; it aligns with a balanced view where leverage is not a dominant concern.
Frequently Asked Questions
What does the Debt-to-Equity Ratio tell investors about MDLZ?
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
How is the Debt-to-Equity Ratio calculated?
Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.
Who are MDLZ's closest peers by Debt-to-Equity Ratio?
The closest peers by Debt-to-Equity Ratio include: ETSY (-2.62x), MCK (-3.00x), TDG (-3.40x), VRSK (-3.81x), MAR (-4.04x).
The Formula
Total Debt / Shareholders' Equity
Why It Matters
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
Master MDLZ's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MDLZ research report →MDLZ
0.82x
Sector Median
0.73x
Sector Avg
0.09x
How MDLZ's Debt-to-Equity Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.